Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.

Land SR, Kopec JA, Julian TB, Brown AM, Anderson SJ, Krag DN, Christian NJ, Costantino JP, Wolmark N, Ganz PA.

J Clin Oncol. 2010 Sep 1;28(25):3929-36. doi: 10.1200/JCO.2010.28.2491. Epub 2010 Aug 2. Erratum in: J Clin Oncol. 2010 Dec 20;28(36):5350.

2.

Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):102-11. Review.

PMID:
14991881
3.

Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.

Seyednejad N, Kuusk U, Wiseman SM.

Expert Rev Anticancer Ther. 2014 Jul;14(7):771-81. doi: 10.1586/14737140.2014.896209. Epub 2014 Mar 13. Review.

PMID:
24621187
4.

Update on the NSABP and ACOSOG breast cancer sentinel node trials.

White RL Jr, Wilke LG.

Am Surg. 2004 May;70(5):420-4. Review.

PMID:
15156950
5.

Axillary node interventions in breast cancer: a systematic review.

Rao R, Euhus D, Mayo HG, Balch C.

JAMA. 2013 Oct 2;310(13):1385-94. doi: 10.1001/jama.2013.277804. Review.

PMID:
24084924
6.

[Management of the axilla in breast cancer: evidences and unresolved issues].

Fodor J, Polgár C, Péley G, Németh G.

Orv Hetil. 2001 Sep 9;142(36):1941-50. Review. Hungarian.

PMID:
11680099
7.

[Positive sentinel node in breast cancer - when and why also opt for axillary dissection?].

Krsička P, Coufal O, Zapletal O.

Rozhl Chir. 2013 Dec;92(12):684-9. Review. Czech.

PMID:
24479511
8.

FDG-PET for axillary lymph node staging in primary breast cancer.

Crippa F, Gerali A, Alessi A, Agresti R, Bombardieri E.

Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S97-102. Epub 2004 May 5. Review.

PMID:
15133635
9.

The changing role of axillary treatment in breast cancer: Who will remain at risk for developing arm morbidity in the future?

Lopez Penha TR, van Roozendaal LM, Smidt ML, Boersma LJ, von Meyenfeldt MF, Voogd AC, Heuts EM.

Breast. 2015 Oct;24(5):543-7. doi: 10.1016/j.breast.2015.04.008. Epub 2015 Jun 6. Review.

PMID:
26051795

Supplemental Content

Support Center